L00 AR presentacion |
1 |
L01-L02 GDM ET imaging_general |
9 |
L03 SJ ICRU 62 + 83 and beyond - Barcelona v1 |
90 |
L04 MKB Image handling presentation_2016_final |
198 |
L05 GDM From uncertainties to margins |
229 |
L06 MKB PR DIR_2016_ final |
265 |
L06 MKB PR Image registration presentation_2016_final |
300 |
L07 ET Lung_anatomy |
336 |
L08 ET Lung [Compatibility Mode] |
363 |
L09 ET PR SS Lung case - physics |
420 |
L09 Lung_Case |
438 |
L10 MA Breast Cancer ESTRO Volumes |
471 |
L11 SS IM CERVIX 2016 |
591 |
L15 AR ESTROTVD |
630 |
L16 CNS planning case outlining - Barcelona 2016 |
692 |
L17 Delineation uncertainties-PR |
709 |
L18 NG TVD_LowerGI |
750 |
GTV and CTV for Rectal Cancer and Anal cancer |
750 |
Slide Number 2 |
751 |
Slide Number 3 |
752 |
CTV: what to include |
753 |
CTV in rectal cancer |
754 |
TME clinical target |
755 |
Slide Number 7 |
756 |
Slide Number 8 |
757 |
Slide Number 9 |
758 |
Slide Number 10 |
759 |
Slide Number 11 |
760 |
Slide Number 12 |
761 |
Slide Number 13 |
762 |
Slide Number 14 |
763 |
Slide Number 15 |
764 |
Slide Number 16 |
765 |
Slide Number 17 |
766 |
Slide Number 18 |
767 |
Slide Number 19 |
768 |
Slide Number 20 |
769 |
Slide Number 21 |
770 |
Slide Number 22 |
771 |
Slide Number 23 |
772 |
Slide Number 24 |
773 |
Slide Number 25 |
774 |
Slide Number 26 |
775 |
Slide Number 27 |
776 |
Slide Number 28 |
777 |
Slide Number 29 |
778 |
Slide Number 30 |
779 |
Slide Number 31 |
780 |
Slide Number 32 |
781 |
Delineation guidelines |
782 |
Slide Number 34 |
783 |
Delineation guidelines |
784 |
Mesorectum: delineation guidelines |
785 |
Mesorectum: delineation guidelines |
786 |
Presacral: delineation guidelines |
787 |
Lateral spaces: delineation guidelines |
788 |
Lateral spaces |
789 |
Lateral spaces |
790 |
Slide Number 42 |
791 |
Slide Number 43 |
792 |
Delineation guidelines |
793 |
Delineation guidelines |
794 |
CTV modulation |
795 |
Slide Number 47 |
796 |
Slide Number 48 |
797 |
Slide Number 49 |
798 |
Slide Number 50 |
799 |
Slide Number 51 |
800 |
Slide Number 52 |
801 |
Inferior pelvic subsite(anal sphincter and ischiorectal fossae) |
802 |
Inferior pelvic subsite |
803 |
CTV modulation |
804 |
Inguinal nodes |
805 |
PTV definition |
806 |
Slide Number 58 |
807 |
ANAL CANCER |
808 |
Slide Number 60 |
809 |
Slide Number 61 |
810 |
Slide Number 62 |
811 |
Slide Number 63 |
812 |
Slide Number 64 |
813 |
Slide Number 65 |
814 |
Slide Number 66 |
815 |
Slide Number 67 |
816 |
Slide Number 68 |
817 |
Slide Number 69 |
818 |
Slide Number 70 |
819 |
Slide Number 71 |
820 |
Slide Number 72 |
821 |
Slide Number 73 |
822 |
Slide Number 74 |
823 |
Slide Number 75 |
824 |
Slide Number 76 |
825 |
Slide Number 77 |
826 |
Slide Number 78 |
827 |
Slide Number 79 |
828 |
Slide Number 80 |
829 |
Slide Number 81 |
830 |
Slide Number 82 |
831 |
Slide Number 83 |
832 |
Slide Number 84 |
833 |
PTV |
834 |
Rectal cancer guidelines: what is going on… |
835 |
Pelvis Delineation Guidelines |
836 |
Pelvis Delineation Guidelines |
837 |
Slide Number 89 |
838 |
Rectal Cancer Delineation GuidelinesAGREEMENT and DISAGREEMENT |
839 |
Slide Number 91 |
840 |
Slide Number 92 |
841 |
Slide Number 93 |
842 |
Slide Number 94 |
843 |
Slide Number 95 |
844 |
Slide Number 96 |
845 |
Slide Number 97 |
846 |
Slide Number 98 |
847 |
Slide Number 99 |
848 |
Slide Number 100 |
849 |
Slide Number 101 |
850 |
Slide Number 102 |
851 |
Slide Number 103 |
852 |
Slide Number 104 |
853 |
Slide Number 105 |
854 |
Slide Number 106 |
855 |
Slide Number 107 |
856 |
Slide Number 108 |
857 |
Slide Number 109 |
858 |
Slide Number 110 |
859 |
Experts delineation according different GL |
860 |
AIM of the project: to generate COMMON DELINEATION GUIDELINES in RECTAL CANCER |
861 |
THE PROCESS OF AGREEMENT |
862 |
SELECTED CASES |
863 |
L19 Physics of prostate case |
864 |
L20 imaging Advanced imaging for target |
871 |
L21 gyn_TVD |
958 |
L22 gyn_TVD_postop |
1000 |